List View

By /

Clear

Displaying 1,726 - 1,750 of 2,995

ctDNA in Adjuvant and Metastatic Therapy for GI Cancers: Prime Time?

ctDNA in Adjuvant and Metastatic Therapy for GI Cancers: Prime Time?

Geriatric Oncology: Pitfalls to Deliver Good Care in the Elderly Cancer Patient

Geriatric Oncology: Pitfalls to Deliver Good Care in the Elderly Cancer Patient

Prostate Cancer: Targeted, Hormonal & Novel Pathways in mCRPC

Prostate Cancer: Targeted, Hormonal & Novel Pathways in mCRPC

Novel RT Approaches in Prostate Cancer

Novel RT Approaches in Prostate Cancer

GIST and Soft Tissue Sarcomas: Focus on Personalized Medicine

GIST and Soft Tissue Sarcomas: Focus on Personalized Medicine

Thymoma and Thymic Carcinomas

Thymoma and Thymic Carcinomas

Cancer Disparity from Different Angles: How to Tackle It?

Cancer Disparity from Different Angles: How to Tackle It?

Lack of Access to Novel Cancer Therapies: How to Deal and Approach this Problem? Diversity, Equity, & Inclusion

Lack of Access to Novel Cancer Therapies: How to Deal and Approach this Problem? Diversity, Equity, & Inclusion

Walking Alongside Patients in Cancer

Walking Alongside Patients in Cancer

Novel Advances in Head and Neck Cancer: What is after IO?

Novel Advances in Head and Neck Cancer: What is after IO?

Immunotherapy in Kidney & Bladder Cancer

Immunotherapy in Kidney & Bladder Cancer

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Toxicities in Immunotherapy

Toxicities in Immunotherapy

Melanoma: What is after immunotherapy? More immunomodulation?

Melanoma: What is after immunotherapy? More immunomodulation?

Medical Marijuana: Who, When & How?

Medical Marijuana: Who, When & How?

Telemedicine in Oncology

Telemedicine in Oncology

Management of Osteonecrosis of Jaw and Other Complications from Bisphosphonate and/or RANK Ligand Inhibitors

Management of Osteonecrosis of Jaw and Other Complications from Bisphosphonate and/or RANK Ligand Inhibitors

Survivorship in the Modern Era of Cancer Care: Goals, Measures, and Outcomes

Survivorship in the Modern Era of Cancer Care: Goals, Measures, and Outcomes

Changing Delivery of Chemotherapy for Breast Cancer: The Broad Impact of Antibody Drug Conjugates

Changing Delivery of Chemotherapy for Breast Cancer: The Broad Impact of Antibody Drug Conjugates

Immunotherapy for Breast Cancer: Current and Future Directions

Immunotherapy for Breast Cancer: Current and Future Directions

Optimal Treatment for Early Stage HER2 Positive Breast Cancer: Tailoring Treatment to Response

Optimal Treatment for Early Stage HER2 Positive Breast Cancer: Tailoring Treatment to Response

Sequencing Endocrine Therapy and Targeted Agents for the Treatment of Metastatic HR+/HER2- Breast Cancer

Sequencing Endocrine Therapy and Targeted Agents for the Treatment of Metastatic HR+/HER2- Breast Cancer

Drug Development and New Targeted Agents for Breast Cancer: What Does the Future Hold?

Drug Development and New Targeted Agents for Breast Cancer: What Does the Future Hold?

ctDNA in Lung Cancer: Current State and Future Perspectives

ctDNA in Lung Cancer: Current State and Future Perspectives

Pre-Operative and Metastatic Setting Biomarkers for Immunotherapy in Lung Cancer

Pre-Operative and Metastatic Setting Biomarkers for Immunotherapy in Lung Cancer